Report ID |
19888 |
Drug Identification Number |
02312557 |
Brand name |
BOOSTRIX-POLIO |
Common or Proper name |
Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
MARKETED |
Active Ingredient(s) |
INACTIVATED POLIOVIRUS TYPE I
INACTIVATED POLIOVIRUS TYPE II
INACTIVATED POLIOVIRUS TYPE III
TETANUS TOXOID ADSORBED
DIPHTHERIA TOXOID ADSORBED
PERTUSSIS TOXOID ADSORBED
FILAMENTOUS HAEMAGGLUTININ ADSORBED
PERTACTIN ADSORBED |
Strength(s) |
40D
8D
32D
5.0LF
2.5LF
8MCG
8MCG
2.5MCG |
Dosage form(s) |
SUSPENSION |
Route of administration |
INTRAMUSCULAR |
Packaging size |
10's |
ATC code |
J07CA |
ATC description |
BACTERIAL AND VIRAL VACCINES, COMBINED |
Reason for shortage |
Delay in shipping of the drug. |
Anticipated start date |
|
Actual start date |
2017-11-08 |
Estimated end date |
2017-12-07 |
Actual end date |
2017-12-06 |
Shortage status |
Resolved |
Updated date |
2017-12-07 |
Company comments |
Supply released November 10, 2017 with limited quantity. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
1-800-387-7374 |